溴隐亭治疗前后纤维囊性乳腺病变的组织学改变。

Revista paulista de medicina Pub Date : 1992-11-01

E F Murta, M M de Freitas, M A Velludo

{"title":"溴隐亭治疗前后纤维囊性乳腺病变的组织学改变。","authors":"E F Murta, M M de Freitas, M A Velludo","doi":"","DOIUrl":null,"url":null,"abstract":"Twenty-five women with fibrocystic breast disease were investigated in a double-blind study using treatment with bromocriptine (5 to 7.5 mg/day for 3 months) or placebo. Estradiol and progesterone measurements did not show any changes before, during or after treatment. Serum prolactin levels were reduced during the use of bromocriptine. Histologic evaluation demonstrated a decrease of epithelial hyperplasia and arrest of the cystic dilation picture after treatment with bromocriptine.","PeriodicalId":74720,"journal":{"name":"Revista paulista de medicina","volume":"110 6","pages":"251-6"},"PeriodicalIF":0.0000,"publicationDate":"1992-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.\",\"authors\":\"E F Murta, M M de Freitas, M A Velludo\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Twenty-five women with fibrocystic breast disease were investigated in a double-blind study using treatment with bromocriptine (5 to 7.5 mg/day for 3 months) or placebo. Estradiol and progesterone measurements did not show any changes before, during or after treatment. Serum prolactin levels were reduced during the use of bromocriptine. Histologic evaluation demonstrated a decrease of epithelial hyperplasia and arrest of the cystic dilation picture after treatment with bromocriptine.\",\"PeriodicalId\":74720,\"journal\":{\"name\":\"Revista paulista de medicina\",\"volume\":\"110 6\",\"pages\":\"251-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1992-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista paulista de medicina\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista paulista de medicina","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

在一项双盲研究中，25名患有纤维囊性乳腺疾病的妇女使用溴隐亭(5 - 7.5 mg/天，持续3个月)或安慰剂治疗。雌二醇和黄体酮的测量在治疗前、治疗期间和治疗后没有任何变化。在使用溴隐亭期间血清催乳素水平降低。组织学评估显示上皮增生减少，经溴隐亭治疗后囊性扩张图像停止。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Histologic changes in fibrocystic breast disease before and after treatment with bromocriptine.

Twenty-five women with fibrocystic breast disease were investigated in a double-blind study using treatment with bromocriptine (5 to 7.5 mg/day for 3 months) or placebo. Estradiol and progesterone measurements did not show any changes before, during or after treatment. Serum prolactin levels were reduced during the use of bromocriptine. Histologic evaluation demonstrated a decrease of epithelial hyperplasia and arrest of the cystic dilation picture after treatment with bromocriptine.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Revista paulista de medicina

自引率

0.00%

发文量

期刊最新文献

Carcinosarcoma of the esophagus [Carcinosarcoma of the cervix uteri]. Cushing syndrome due to ectopic ACTH secretion [Diabetic neuropathy]. [Clioquinol].